Jyothy Laboratories received an excise duty order and penalty of ₹20.35 crore from the Commissionerate of Central Goods and Services Tax on August 24, 2026. The demand pertains to the period between April 2016 and June 2017.

The order was issued under Section 11A(10) of the Central Excise Act, 1944, read with Section 174(2) of the Central Goods and Services Tax Act, 2017. It stems from a difference in interpretation regarding the Harmonized System of Nomenclature (HSN) classification of a manufactured product and the resulting excise duty liability.

Demand Breakdown

The total liability includes principal duty, penalty, redemption fine, and applicable interest. The specific components of the demand are detailed below:

Legal Context and Appeal

Jyothy Labs noted that it had previously received a favorable order at another location concerning the same classification dispute. That earlier decision was accepted by the Excise Authorities and was not challenged before higher authorities.

The company is currently in the process of filing an appeal before the appellate authority against this latest order.

Financial Impact Assessment

Management stated that the company does not foresee any material impact on its financials, operations, or other activities consequent to the said order. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Jyothy Laboratories reported a significant decline in profitability for the quarter ended June 30, 2026, as net profit after tax fell 51% year-on-year to ₹47.64 crore. Despite a modest increase in top-line growth, the company’s earnings per share (EPS) dropped to ₹1.30, down from ₹2.64 in the same period last year.

The Board of Directors, chaired by Ms. M. R. Jyothy, approved the unaudited financial results at a meeting held on August 12, 2026. The results were reviewed by the Audit Committee prior to approval.

Financial Performance Overview

Revenue from operations rose 3% year-on-year to ₹773.4 crore, up from ₹751.21 crore in Q1FY25. However, this revenue growth did not translate into proportional profit expansion. Net profit before tax declined 49% to ₹64.98 crore from ₹127.53 crore in the corresponding quarter of the previous fiscal year.

On a sequential basis, the results also showed a downturn compared to the immediately preceding quarter (Q4FY26). Revenue increased slightly to ₹773.4 crore from ₹717.41 crore, but net profit after tax fell 29% to ₹47.64 crore from ₹67.52 crore.

What the Numbers Show

The divergence between revenue growth and profit contraction highlights severe margin compression during the quarter. While sales expanded by approximately ₹22.19 crore year-on-year, net profit before tax nearly halved. This suggests that cost structures or input prices may have risen disproportionately to revenue generation, eroding operational efficiency. The effective tax rate remained stable at approximately 27%, indicating that the profit decline was driven primarily by pre-tax operational factors rather than tax regime changes.

Segment Reporting Update

The company revised its internal management segment reporting structure during the quarter. The Chief Operating Decision Maker now reviews the business under three reportable segments: Fabric Care, Home Care, and Personal Care. Comparative segment information for previous periods has been restated accordingly, though these restated figures have not been subjected to limited review or audit.